期刊文献+

清凉除银汤联合湿润烧伤膏治疗银屑病的临床疗效观察 被引量:2

Clinical Efficacy Observation of Qing Liang Chu Yin Tang in Combination with MEBO in the Treatment of Psoriasis
下载PDF
导出
摘要 目的观察清凉除银汤联合湿润烧伤膏治疗血热内蕴型银屑病的临床疗效。方法将满足纳入标准的92例血热内蕴型银屑病患者随机分为治疗组(46例)和对照组(46例),治疗组采用清凉除银汤联合湿润烧伤膏治疗,对照组采用丹青胶囊联合湿润烧伤膏治疗,以8周为治疗周期,比较两组患者治疗前后的PASI评分。结果治疗前及治疗后2周,治疗组与对照组的PASI分值无统计学差异(P》0.05);治疗组治疗后4、8周与治疗前相比,PASI分值具有统计学差异(P<0.05);对照组治疗后4、8周与治疗前相比,PASI分值具有统计学差异(P<0.05);治疗后4、8周,治疗组与对照组的PASI分值具有统计学差异(P<0.05)。治疗组的总有效率(76%)明显优于对照组(57%)(P<0.05)。结论清凉除银汤联合湿润烧伤膏治疗血热内蕴型银屑病疗效较好,值得临床推广应用。 Objective To observe the clinical efficacy of Qing Liang Chu Yin Tang combined with MEBO in treating psoriasis.Methods 92 patients meeting inclusion criteria were randomly divided into a treatment group and a control group(46 cases in each).The treatment group was treated with Qing Liang Chu Yi Tang and external application of MEBO,while the control group was treated with Danqing Capsule plus external application of MEBO.One treatment course included8 weeks.The PASI scores of the two groups were compared.Results There was no statistically significant difference between the treatment group and the control group when PASI scores were compared before the treatment and on week 2 after the treatment(P〈0.05).PASI scores on week 4 and 8 after the treatment in the treatment group differed from PASI score before the treatment significantly(P〈0.05 respectively) and the same was true for the control group.Moreover the PASI scores on week 4 and week 8 in the treatment group had statistically significant differences from that in the control group(P〈0.05 respectively).The total effective rate in the treatment group was obviously superior to that in the control group(76%vs.57%,P〈0.05).Conclusion Qing Liang Chu Yi Tang combined with MEBO is an effective protocol of treating psoriasis and is worthy of clinical promotion and application.
出处 《中国烧伤创疡杂志》 2015年第6期442-444,共3页 The Chinese Journal of Burns Wounds & Surface Ulcers
关键词 银屑病 血热证 湿润烧伤膏 清凉除银汤 疗效 Psoriasis Heat in blood system MEBO Qing Liang Chu Yin Tang Efficacy
  • 相关文献

参考文献7

二级参考文献17

  • 1[1]Chan FL, Choi HL, Chen ZY, et al. Induction of apoptosis in prostate cancer cell lines by a flavonoid, baicalin[J]. Cancer Lett,2000,160(2):219-228.
  • 2[2]Werner S, Smole H. Paracrine regulation of keratinocyte proliferation and differention[J]. Trends Cell Biol,2001,11(4):143-146.
  • 3[3]Oyama N, Iwatsuke K, Satoh M, et al. Dermal fibroblasts are one of the therapeutic targets for topical application of 1 alpha,25-dihydroxyvitamin D3: the possible involvement of transforming growth factor-beta induction[J]. Br J Dermatol,2000,143(6): 1140-1148.
  • 4[4]Miura H, Sano S, Higashiyama M, et al. Involvement of insulinlike growth factor-1 in psoriasis as a paracrine growth factor: dermal fibroblasts play a regulatory role in developing psoriatic lesions[J]. Arch Dermatol Res,2000,292(12):590-597.
  • 5[5]Ikezoe T, Chen SS, Heber D, et al. Baicalin is a major component of PC-SPES which inhibits the proliferation of human cancer cells via apoptosis and cell cycle arrest[J]. Prostate,2001,49(4):285-292.
  • 6[6]Stein M, Bernd A, Ramirez-Bosca A, et al. Measurement of anti-inflammatory effects of glucocorticoids on human keratinocytes in vitro. Comparison of normal human kertinocytes with the keratinocyte cell line HaCaT[J]. Arzneimittelforschung, 1997,47:1266-1270.
  • 7[7]Chen S, Ruan Q, Bedner E, et al. Effects of the flavonoid baicalin and its metabolite bacalein on androgen receptor expression, cell cycle progression and apoptosis of prostate cancer cell lines [J].Cell Prolif,2001,34(5):293-304.
  • 8[8]Dimon-Gadal S, Raynaud F, Evain-Brion D, et al. MAP kinase abnormalities in hyperproliferative cultured fibroblasts from psoriatic skin[J]. J Invest Dermatol,1998,110 (6):872-879.
  • 9AT布朗.基因组[M].北京:科学出版社,2002.283.
  • 10中国中西医结合学会烧伤专业委员会.烧伤医疗技术蓝皮书[M].北京:中国医药科技出版社,2000.35-49.

共引文献69

同被引文献55

引证文献2

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部